Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Expert Review of Vaccines
|
June 4, 2010
Vaccine-induced antibody responses in patients with carcinoma
Silvia von Mensdorff-Pouilly
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
July 12, 2005
What makes MUC1 a tumor antigen?
Uwe Karsten, Silvia von Mensdorff-Pouilly, Steffen Goletz
Cancer Research
|
September 6, 2005
Molecular basis of incomplete O-glycan synthesis in MCF-7 breast cancer cells: putative role of MUC6 in Tn antigen expression
Teresa Freire, Sylvie Bay, Silvia von Mensdorff-Pouilly, et al.
Cancers
|
November 12, 2013
Natural and Induced Humoral Responses to MUC1
Silvia Von Mensdorff-Pouilly, Maria Moreno, René H M Verheijen
Cancer Research
|
June 4, 2008
Immunoglobulin allotypes influence antibody responses to mucin 1 in patients with gastric cancer
Janardan P Pandey, Paul J Nietert, Silvia von Mensdorff-Pouilly, et al.
Cancer Letters
|
August 19, 2007
High level of MUC1 in serum of ovarian and breast cancer patients inhibits huHMFG-1 dependent cell-mediated cytotoxicity (ADCC)
María Moreno, Hetty J Bontkes, Rik J Scheper, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 23, 2011
Open versus laparoscopic pelvic lymph node dissection in early stage cervical cancer: no difference in surgical or disease outcome
Jonas van de Lande, Silvia von Mensdorff-Pouilly, Roelof G Lettinga, et al.
Journal of Cancer Research and Clinical Oncology
|
September 21, 2002
Cellular and humoral responses after multiple injections of unconjugated chimeric monoclonal antibody MOv18 in ovarian cancer patients: a pilot study
Iwona van Zanten-Przybysz, Carla Molthoff, Jacqueline Klein Gebbinck, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
May 24, 2008
A combination of serum tumor markers identifies high-risk patients with early-stage squamous cervical cancer
Elvira M Davelaar, Jonas van de Lande, Silvia von Mensdorff-Pouilly, et al.
Annals of Clinical Biochemistry
|
November 25, 2003
Clinical and technical evaluation of the ACS:OV serum assay and comparison with three other CA125-detecting assays
Elvira M Davelaar, Eltjo M J Schutter, Silvia von Mensdorff-Pouilly, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Expert Review of Vaccines
|
June 4, 2010
Vaccine-induced antibody responses in patients with carcinoma
Silvia von Mensdorff-Pouilly
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
July 12, 2005
What makes MUC1 a tumor antigen?
Uwe Karsten, Silvia von Mensdorff-Pouilly, Steffen Goletz
Cancer Research
|
September 6, 2005
Molecular basis of incomplete O-glycan synthesis in MCF-7 breast cancer cells: putative role of MUC6 in Tn antigen expression
Teresa Freire, Sylvie Bay, Silvia von Mensdorff-Pouilly, et al.
Cancers
|
November 12, 2013
Natural and Induced Humoral Responses to MUC1
Silvia Von Mensdorff-Pouilly, Maria Moreno, René H M Verheijen
Cancer Research
|
June 4, 2008
Immunoglobulin allotypes influence antibody responses to mucin 1 in patients with gastric cancer
Janardan P Pandey, Paul J Nietert, Silvia von Mensdorff-Pouilly, et al.
Cancer Letters
|
August 19, 2007
High level of MUC1 in serum of ovarian and breast cancer patients inhibits huHMFG-1 dependent cell-mediated cytotoxicity (ADCC)
María Moreno, Hetty J Bontkes, Rik J Scheper, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 23, 2011
Open versus laparoscopic pelvic lymph node dissection in early stage cervical cancer: no difference in surgical or disease outcome
Jonas van de Lande, Silvia von Mensdorff-Pouilly, Roelof G Lettinga, et al.
Journal of Cancer Research and Clinical Oncology
|
September 21, 2002
Cellular and humoral responses after multiple injections of unconjugated chimeric monoclonal antibody MOv18 in ovarian cancer patients: a pilot study
Iwona van Zanten-Przybysz, Carla Molthoff, Jacqueline Klein Gebbinck, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
May 24, 2008
A combination of serum tumor markers identifies high-risk patients with early-stage squamous cervical cancer
Elvira M Davelaar, Jonas van de Lande, Silvia von Mensdorff-Pouilly, et al.
Annals of Clinical Biochemistry
|
November 25, 2003
Clinical and technical evaluation of the ACS:OV serum assay and comparison with three other CA125-detecting assays
Elvira M Davelaar, Eltjo M J Schutter, Silvia von Mensdorff-Pouilly, et al.
Page
of 3